Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H22FN3O |
| Molecular Weight | 375.4387 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FCCCCCN1C=C(C(=O)NC2=CC=CC3=CC=CC=C23)C4=CN=CC=C14
InChI
InChIKey=BRRZRRZUERBDQL-UHFFFAOYSA-N
InChI=1S/C23H22FN3O/c24-12-4-1-5-14-27-16-20(19-15-25-13-11-22(19)27)23(28)26-21-10-6-8-17-7-2-3-9-18(17)21/h2-3,6-11,13,15-16H,1,4-5,12,14H2,(H,26,28)
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-5F-PCN
Created by
admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
125181244
Created by
admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
|
PRIMARY | |||
|
DTXSID901032641
Created by
admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
|
PRIMARY | |||
|
2219332-48-4
Created by
admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
|
PRIMARY | |||
|
Q7GH2GGJ3E
Created by
admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
|
PRIMARY | |||
|
5F-PCN
Created by
admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
|
PRIMARY | CAS: 325373-36-9 given is a non valid CAS Registry Number. | ||
|
5F-PCN
Created by
admin on Sat Dec 16 10:37:32 GMT 2023 , Edited by admin on Sat Dec 16 10:37:32 GMT 2023
|
PRIMARY | 5F-PCN (also known as 5-F-MN-21) is an azaindole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is closely related to NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-PCN may release 1-naphthylamine, a known carcinogen. Sweden's public health agency suggested to classify 5F-PCN as hazardous substance on November 10, 2014. |
ACTIVE MOIETY
